FOXO4-DRI
£194.99
If you are looking for a Certificate Of Analysis, please email research@peptidesuk.co.uk to have it sent to you.
Please Note: Many sites are displaying counterfeit COAs, so ours is provided upon request.
You may also like…
Product Description
FOXO4-DRI (Forkhead box O4 D-Retro-Inverso) is a synthetic peptide developed to selectively target and eliminate senescent cells. It disrupts the interaction between FOXO4 and p53, inducing apoptosis in damaged, non-dividing senescent cells without affecting healthy cells. FOXO4-DRI is a leading compound in the field of senolytics, studied for its role in anti-aging, tissue rejuvenation, and degenerative disease models.
Benefits (Based on Preclinical Research)
-
Promotes selective apoptosis of senescent cells
-
Supports tissue regeneration and rejuvenation
-
Improves cellular health and mitochondrial function
-
Studied for reversing age-related decline in organs
-
Explored in models of osteoarthritis, frailty, and neurodegeneration
Who Uses This
FOXO4-DRI is used by researchers in longevity science, regenerative medicine, oncology, and cellular aging to study senescence-associated diseases and lifespan extension.
Why Choose FOXO4-DRI
-
Precisely targets senescent cells through p53/FOXO4 interference
-
Supplied as sterile, lyophilized peptide
-
HPLC and MS validated with high purity
-
Includes full Certificate of Analysis and lab-grade documentation
Documentation and Quality
Each batch of FOXO4-DRI is supplied with COA, purity verification, and handling instructions. Shipped in tamper-proof, cold-chain packaging to preserve structural integrity.
Disclaimer
FOXO4-DRI is intended for research use only. It is not approved for human consumption or therapeutic use. Only licensed laboratories and qualified personnel may handle this compound.
